Publication:
The impact of visible tumor (PI-RADS >= 3) on upgrading and adverse pathology at radical prostatectomy in low risk prostate cancer patients: a biopsy core based analysis

Simple item page
dc.contributor.coauthorKılıç, Mert
dc.contributor.coauthorSağlıcan, Yeşim
dc.contributor.coauthorTuğcu, Volkan
dc.contributor.coauthorBakır, Barış
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.facultymemberYes
dc.contributor.kuauthorBalbay, Mevlana Derya
dc.contributor.kuauthorBaydar, Dilek Ertoy
dc.contributor.kuauthorCanda, Abdullah Erdem
dc.contributor.kuauthorÇil, Barbaros Erhan
dc.contributor.kuauthorEsen, Tarık
dc.contributor.kuauthorKiremit, Murat Can
dc.contributor.kuauthorKordan, Yakup
dc.contributor.kuauthorKöseoğlu, Ersin
dc.contributor.kuauthorÖzkan, Arif
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2024-11-09T23:37:28Z
dc.date.issued2022
dc.description.abstractDeciding on the management of prostate cancer (PCa), especially GG1 PCa, is quite difficult. The most important thing that will help us in making active surveillance or definitive treatment decision is whether the tumor is a clinically significant tumor. To understand this, we discussed in this article that multiparametric MR, PI-RADS scoring and targeted biopsy can be used. Background
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.peerreviewstatusPeer-Reviewed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.WoSQuartileQ2
dc.identifier.doi10.1016/j.clgc.2021.09.007
dc.identifier.eissn1938-0682
dc.identifier.embargoN/A
dc.identifier.endpageE67
dc.identifier.issn1558-7673
dc.identifier.issue1
dc.identifier.pubmed34750082
dc.identifier.scopus2-s2.0-85118833159
dc.identifier.startpageE61
dc.identifier.urihttps://doi.org/10.1016/j.clgc.2021.09.007
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12834
dc.identifier.volume20
dc.identifier.wos000791221900016
dc.keywordsMultiparametric prostate magnetic resonance imaging
dc.keywordsFusion biopsy
dc.keywordsProstate cancer
dc.keywordsPi-Rads targeted biopsies
dc.keywordsDiagnosis
dc.keywordsImage
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofClinical Genitourinary Cancer
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectOncology
dc.subjectUrology
dc.subjectNephrology
dc.titleThe impact of visible tumor (PI-RADS >= 3) on upgrading and adverse pathology at radical prostatectomy in low risk prostate cancer patients: a biopsy core based analysis
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorÖzkan, Arif
local.contributor.kuauthorKöseoğlu, Ersin
local.contributor.kuauthorBalbay, Mevlana Derya
local.contributor.kuauthorCanda, Abdullah Erdem
local.contributor.kuauthorKordan, Yakup
local.contributor.kuauthorKiremit, Murat Can
local.contributor.kuauthorEsen, Tarık
local.contributor.kuauthorBaydar, Dilek Ertoy
local.contributor.kuauthorÇil, Barbaros Erhan
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext